KEZAR LIFE SCIENCES INC (KZR)

US49372L1008 - Common Stock

0.7998  0 (-0.2%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KZR. KZR was compared to 588 industry peers in the Biotechnology industry. While KZR seems to be doing ok healthwise, there are quite some concerns on its profitability. KZR has a expensive valuation and it also scores bad on growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

KZR had negative earnings in the past year.
In the past year KZR has reported a negative cash flow from operations.
KZR had negative earnings in each of the past 5 years.
In the past 5 years KZR always reported negative operating cash flow.

1.2 Ratios

KZR has a Return On Assets (-46.05%) which is in line with its industry peers.
With a decent Return On Equity value of -54.31%, KZR is doing good in the industry, outperforming 65.07% of the companies in the same industry.
Industry RankSector Rank
ROA -46.05%
ROE -54.31%
ROIC N/A
ROA(3y)-31.3%
ROA(5y)-32.12%
ROE(3y)-35.78%
ROE(5y)-36.39%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KZR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

4

2. Health

2.1 Basic Checks

KZR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KZR has more shares outstanding
Compared to 5 years ago, KZR has more shares outstanding
The debt/assets ratio for KZR is higher compared to a year ago.

2.2 Solvency

KZR has an Altman-Z score of -1.69. This is a bad value and indicates that KZR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.69, KZR is in line with its industry, outperforming 51.54% of the companies in the same industry.
KZR has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.05, KZR is not doing good in the industry: 61.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -1.69
ROIC/WACCN/A
WACC9.43%

2.3 Liquidity

A Current Ratio of 11.66 indicates that KZR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 11.66, KZR belongs to the top of the industry, outperforming 83.73% of the companies in the same industry.
KZR has a Quick Ratio of 11.66. This indicates that KZR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 11.66, KZR belongs to the top of the industry, outperforming 83.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.66
Quick Ratio 11.66

More info and screens

3

3. Growth

3.1 Past

The earnings per share for KZR have decreased strongly by -39.60% in the last year.
EPS 1Y (TTM)-39.6%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

Based on estimates for the next years, KZR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.60% on average per year.
Based on estimates for the next years, KZR will show a very strong growth in Revenue. The Revenue will grow by 63.57% on average per year.
EPS Next Y3.13%
EPS Next 2Y4.97%
EPS Next 3Y3.61%
EPS Next 5Y11.6%
Revenue Next Year-58.33%
Revenue Next 2Y-22.84%
Revenue Next 3Y-25.99%
Revenue Next 5Y63.57%

3.3 Evolution

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KZR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year KZR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.97%
EPS Next 3Y3.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KZR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KEZAR LIFE SCIENCES INC

NASDAQ:KZR (4/25/2024, 11:20:52 AM)

0.7998

0 (-0.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap58.23M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.05%
ROE -54.31%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 11.66
Quick Ratio 11.66
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-39.6%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y3.13%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y